Head of Investor Relations Welcome to the Q4 and full year 2024 conference call for investors and analysts. As usual, you can find the slides on sanofi.com. Please turn to Slide 3. Here we have the ...

Q4 2024 Earnings Conference Call February 4, 2025 5:00 PM ETCompany ParticipantsChris Potochar – Vice President of ...

A quick online search of “vaping hazards” will direct you toward a number of articles and fact sheets addressing ... as we do with chronic obstructive pulmonary disease (COPD) patients?

Roche Holding AG delivered a strong set of 2024 earnings. Guidance for 2025 suggests this will be a transitional year ahead, ...

Welcome to the Q2 fiscal-year 2025 ResMed earnings conference call. My name is Matt and I'll be your operator for today's call. (Operator Instructions) Please note that this conference call is being ...

Q2 2025 Earnings Call Transcript January 30, 2025 ResMed Inc. beats earnings expectations. Reported EPS is $2.43, expectations were $2.32. Operator: Welcome to the Q2 Fiscal Year 2025 ResMed Earnings ...

“Despite its size, Dupixent can see low double-digit growth per annum into the next decade due to greater penetration of existing indications, younger age groups, new geographies and a recent approval ...

Synairgen PLC is a respiratory drug discovery and development company. It is engaged in the drug discovery and development of therapies for respiratory diseases, particularly in the areas, including ...

During and after an exacerbation, mental recovery involves taking care of both your physical and mental health. Resting, ...

You must go to a doctor to know for sure whether you have COPD. That’s because there are things to consider for a diagnosis. Some people have asthma and COPD at the same time. If you have ...